Systematic pan-cancer analysis identifies transmembrane protein 158 as a potential therapeutic, prognostic and immunological biomarker.

Li J, Hou H, Sun J, Ding Z, Xu Y, Li G

Open source

DOI
10.1007/s10142-023-01032-0
Published
2023 Mar 28
Container
Functional & integrative genomics
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s10142-023-01032-0,
  title = {Systematic pan-cancer analysis identifies transmembrane protein 158 as a potential therapeutic, prognostic and immunological biomarker.},
  author = {Li J and Hou H and Sun J and Ding Z and Xu Y and Li G},
  year = {2023},
  journal = {Functional \& integrative genomics},
  doi = {10.1007/s10142-023-01032-0},
  url = {https://doi.org/10.1007/s10142-023-01032-0}
}

RIS

TY  - JOUR
TI  - Systematic pan-cancer analysis identifies transmembrane protein 158 as a potential therapeutic, prognostic and immunological biomarker.
AU  - Li J
AU  - Hou H
AU  - Sun J
AU  - Ding Z
AU  - Xu Y
AU  - Li G
PY  - 2023
JO  - Functional & integrative genomics
DO  - 10.1007/s10142-023-01032-0
UR  - https://doi.org/10.1007/s10142-023-01032-0
ER  - 

APA

J, L., H, H., J, S., Z, D., Y, X., & G, L. (2023). Systematic pan-cancer analysis identifies transmembrane protein 158 as a potential therapeutic, prognostic and immunological biomarker.. Functional & integrative genomics. https://doi.org/10.1007/s10142-023-01032-0

Source records